CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,543,864 | -2.8% | 228,784 | 0.0% | 0.37% | +4.2% |
| Q1 2024 | $3,646,817 | -5.2% | 228,784 | 0.0% | 0.36% | -9.7% |
| Q4 2023 | $3,845,859 | +40.4% | 228,784 | -2.3% | 0.39% | +22.4% |
| Q3 2023 | $2,738,780 | -31.3% | 234,284 | -21.0% | 0.32% | -27.9% |
| Q2 2023 | $3,984,906 | -21.0% | 296,496 | -2.5% | 0.44% | -27.8% |
| Q1 2023 | $5,043,487 | -10.9% | 304,191 | -0.0% | 0.62% | -14.1% |
| Q4 2022 | $5,658,771 | +44.9% | 304,235 | -0.0% | 0.72% | +6.9% |
| Q3 2022 | $3,904,000 | +82.9% | 304,293 | -0.1% | 0.67% | +28.8% |
| Q2 2022 | $2,135,000 | -15.4% | 304,515 | 0.0% | 0.52% | +1.8% |
| Q1 2022 | $2,524,000 | -38.8% | 304,515 | -50.0% | 0.51% | +21.3% |
| Q4 2021 | $4,124,000 | +155.5% | 609,030 | +100.0% | 0.42% | +19.9% |
| Q3 2021 | $1,614,000 | -54.1% | 304,515 | -50.2% | 0.35% | -44.2% |
| Q2 2021 | $3,514,000 | +24.9% | 611,107 | +0.1% | 0.63% | +23.0% |
| Q1 2021 | $2,814,000 | +123.9% | 610,491 | +62.3% | 0.51% | +91.4% |
| Q4 2020 | $1,257,000 | – | 376,207 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |